COLL - Collegium Pharmaceutical, Inc - SEC Form 4 Insider Trading Screener
19 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-02-15 | COLL | Heffernan Michael Thomas | Dir | S - Sale | $14.81 | -25,000 | 252,362 | -9% | -$370,224 | ||||||
2019-01-15 | COLL | Heffernan Michael Thomas | Dir | S - Sale | $15.56 | -25,000 | 286,000 | -8% | -$389,000 | ||||||
2018-12-17 | COLL | Heffernan Michael Thomas | Dir | S - Sale | $18.18 | -25,000 | 311,000 | -7% | -$454,491 | ||||||
2018-11-15 | COLL | Heffernan Michael Thomas | Dir | S - Sale | $16.60 | -25,000 | 336,000 | -7% | -$415,122 | ||||||
2018-10-15 | COLL | Heffernan Michael Thomas | Dir | S - Sale | $16.53 | -25,000 | 361,000 | -6% | -$413,250 | ||||||
2018-06-21 | COLL | Brannelly Paul | EVP, CFO | S - Sale | $27.92 | -10,000 | 123,436 | -7% | -$279,165 | ||||||
2018-06-12 | COLL | Fleming Alison B | CTO | S - Sale | $27.00 | -4,096 | 53,362 | -7% | -$110,592 | ||||||
| M | 2018-06-11 | COLL | Heffernan Michael Thomas | COB, Pres, CEO | S - Sale | $25.27 | -150,000 | 388,693 | -28% | -$3,790,939 | |||||
| DM | 2018-05-31 | COLL | Ciaffoni Joseph | COO | S - Sale+OE | $22.59 | -79,683 | 88,201 | -47% | -$1,799,713 | |||||
2018-05-10 | COLL | Heffernan Michael Thomas | COB, Pres, CEO | S - Sale | $26.21 | -7,100 | 538,693 | -1% | -$186,100 | ||||||
2018-04-19 | COLL | Heffernan Michael Thomas | COB, Pres, CEO | S - Sale | $26.00 | -44,400 | 545,793 | -8% | -$1,154,401 | ||||||
| M | 2018-01-22 | COLL | Heffernan Michael Thomas | COB, Pres, CEO | S - Sale | $25.01 | -20,000 | 1,054,382 | -2% | -$500,164 | |||||
2018-01-19 | COLL | Heffernan Michael Thomas | COB, Pres, CEO | S - Sale | $22.50 | -20,000 | 538,987 | -4% | -$450,000 | ||||||
| D | 2018-01-10 | COLL | Fleming Alison B | CTO | S - Sale+OE | $19.07 | -6,928 | 25,723 | -21% | -$132,117 | |||||
2017-12-08 | COLL | Hirsch David | Dir, 10% | S - Sale | $17.34 | -1,000,000 | 2,321,842 | -30% | -$17,340,000 | ||||||
2017-12-08 | COLL | Longitude Capital Partners, LLC | 10% | S - Sale | $17.34 | -1,000,000 | 2,321,842 | -30% | -$17,340,000 | ||||||
| DM | 2017-11-17 | COLL | Fleming Alison B | CTO | S - Sale+OE | $17.25 | -4,601 | 25,723 | -15% | -$79,361 | |||||
2017-11-15 | COLL | Heffernan Michael Thomas | COB, Pres, CEO | S - Sale | $15.53 | -50,000 | 558,987 | -8% | -$776,500 | ||||||
2017-05-12 | COLL | Brannelly Paul | EVP, CFO | P - Purchase | $9.18 | +10,000 | 110,227 | +10% | +$91,800 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |